Construction of a PLGA based, targeted siRNA delivery system for treatment of osteoporosis

References

• Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:671–685. Epub 2008/11/26.10.1016/j.beem.2008.06.001
   PubMed Web of Science ®Google Scholar
• Kanis JA. Assessment of osteoporosis at the primary health care level. Sheffield: World Heath Organization Scientific Group Technical Report, University of Sheffield: 66. 2007.
   Google Scholar
• Akesson K. New approaches to pharmacological treatment of osteoporosis. Bull World Health Organ. 2003;81:657–664 . Epub 2004/01/09.
   PubMed Web of Science ®Google Scholar
• Das S, Crockett JC. Osteoporosis – a current view of pharmacological prevention and treatment. Drug Des Dev Ther. 2013;7:435–448 . Epub 2013/06/29.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dusad A, Ren K. Drug delivery strategies for treating osteoporosis. Orthopedic Muscul Sys. 2014;S2:003. doi:10.4172/2161-0533.S2-003.
   Google Scholar
• Fazil M, Ali A, Baboota S, et al. Exploring drug delivery systems for treating osteoporosis. Expert Opin Drug Delivery. 2013;10:1123–1136 . Epub 2013/03/30.10.1517/17425247.2013.785518
   PubMed Web of Science ®Google Scholar
• Carbone EJ, Rajpura K, Allen BN, et al. Osteotropic nanoscale drug delivery systems based on small molecule bone-targeting moieties. Nanomed Nanotechnol Biol Med. 2017;13:37–47.10.1016/j.nano.2016.08.015
   PubMed Web of Science ®Google Scholar
• Miladi K, Sfarb S, Fessia H, et al. Drug carriers in osteoporosis: preparation, drug encapsulation and applications. Int J Pharm. 2013;445:181–195.10.1016/j.ijpharm.2013.01.031
   PubMed Web of Science ®Google Scholar
• Shi X, Wang Y, Ren L, et al. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm Res. 2009;26:422–430.10.1007/s11095-008-9759-0
   PubMed Web of Science ®Google Scholar
• Narayanan D, Anitha A, Jayakumar R, et al. Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis. J Biomed Nanotechnol. 2012;8:98–106 . Epub 2012/04/21.10.1166/jbn.2012.1367
   PubMed Web of Science ®Google Scholar
• Hosny KM. Alendronate sodium as enteric coated solid lipid nanoparticles; preparation, optimization, and ın vivo evaluation to enhance Its oral bioavailability. PLoS One. 2016;11:e0154926.10.1371/journal.pone.0154926
   PubMed Web of Science ®Google Scholar
• Fazil M, Hassan MQ, Baboota S, et al. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis. Drug Delivery. 2016;23:2428–2438.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498.10.1038/35078107
   PubMed Web of Science ®Google Scholar
• Liu X. Bone site-specific delivery of siRNA. J Biomed Res. 2016;30:264–271.
   PubMed Web of Science ®Google Scholar
• Fahid FSJ, Zhu Q, Zhang C. Application of small ınterfering RNA for ınhibition of lipopolysaccharide-induced osteoclast formation and cytokine stimulation. J Endod. 2008;34:563–569.10.1016/j.joen.2008.01.024
   PubMed Web of Science ®Google Scholar
• Wang Y, Grainger DW. siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption. Pharm Res. 2010;27:1273–1284.10.1007/s11095-010-0099-5
   PubMed Web of Science ®Google Scholar
• Choi B, Cui ZK, Kim S, et al. Glutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation. J Mater Chem B. 2015;3:6448–6455.10.1039/C5TB00843C
   PubMed Web of Science ®Google Scholar
• Wang Y, Tran KK, Shen H, et al. Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials. Biomaterials. 2012;33:8540–8547.10.1016/j.biomaterials.2012.07.039
   PubMed Web of Science ®Google Scholar
• Manaka T, Suzuki A, Takayama K, et al. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials. 2011;32:9642–9648.10.1016/j.biomaterials.2011.08.026
   PubMed Web of Science ®Google Scholar
• Wang Y, Grainger DW. Developing siRNA therapies to address osteoporosis. Ther Delivery. 2013;4:1239–1246.10.4155/tde.13.85
   PubMedGoogle Scholar
• Shegokar R, Al Shaal L, Mishra PR. SiRNA delivery: challenges and role of carrier systems. Die Pharm – An Int J Pharm Sci. 2011;66:313–318.
   Google Scholar
• Zhang Y, Wei L, Miron RJ, et al. Anabolic bone formation via a site-specific bone-targeting delivery system by ınterfering with semaphorin 4d expression. J Bone Miner Res. 2015;30:286–296.10.1002/jbmr.2322
   PubMed Web of Science ®Google Scholar
• Liang C, Guo B, Wu H, et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat Med. 2015;21:288–294 . Epub 2015/02/11.10.1038/nm.3791
   PubMed Web of Science ®Google Scholar
• Zhang G, Guo B, Wu H, et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med. 2012;18:307–314.10.1038/nm.2617
   PubMed Web of Science ®Google Scholar
• Sun Y, Ye X, Cai M, et al. Osteoblast-targeting-peptide modified nanoparticle for siRNA/microRNA delivery. ACS Nano. 2016;10:5759–5768.10.1021/acsnano.5b07828
   PubMed Web of Science ®Google Scholar
• Utsuno K, Uludag H. Thermodynamics of polyethylenimine-DNA binding and DNA condensation. Biophys J. 2010;99:201–207.10.1016/j.bpj.2010.04.016
   PubMed Web of Science ®Google Scholar
• Dominska M, Dykxhoorn DM. Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci. 2010;123(8):1183–1189.
   PubMed Web of Science ®Google Scholar
• Hall A, Larsen AK, Parhamifar L, et al. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: mitochondrial proton leak and inhibition of the electron transport system. Biochim Biophy Acta (BBA) – Bioenerg. 2013;1827:1213–1225 . Epub 2013/07/16.10.1016/j.bbabio.2013.07.001
   PubMed Web of Science ®Google Scholar
• Alshamsan A, Haddadi A, Hamdy S, et al. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer ımmune response. Mol Pharm. 2010;7:1643–1654.10.1021/mp100067u
   PubMed Web of Science ®Google Scholar
• Sahana DK, Mittal G, Bhardwaj V, et al. PLGA nanoparticles for oral delivery of hydrophobic drugs: ınfluence of organic solvent on nanoparticle formation and release behavior ın vitro and ın vivo using estradiol as a model drug. J Pharm Sci. 2008;97:1530–1542 . Epub 2007/08/28.10.1002/jps.21158
   PubMed Web of Science ®Google Scholar
• Gomez-Gaete C, TSAPIS N, BESNARD M, et al. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm. 2007;331:153–159 . Epub 2006/12/13.10.1016/j.ijpharm.2006.11.028
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B. 2010;75:1–18.10.1016/j.colsurfb.2009.09.001
   PubMed Web of Science ®Google Scholar
• Pradhan R, Poudel BK, Ramasamy T, et al. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies. J Nanosci Nanotechnol. 2013;13:5948–5956 . Epub 2013/07/26.10.1166/jnn.2013.7735
   PubMed Web of Science ®Google Scholar
• Khan A, Benboubetra M, Sayyed PZ, et al. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J Drug Targeting. 2004;12:393–404.10.1080/10611860400003858
   PubMed Web of Science ®Google Scholar
• Zhou J, Patel TR, Fu M, et al. Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. Biomaterials. 2012;33:583–591.10.1016/j.biomaterials.2011.09.061
   PubMed Web of Science ®Google Scholar
• Vasır JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Delivery Rev. 2007;59:718–728.10.1016/j.addr.2007.06.003
   PubMed Web of Science ®Google Scholar
• Panyam J, Zhou WZ, Prabha S, et al. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002;16:1217–1226 . Epub 2002/08/03.10.1096/fj.02-0088com
   PubMed Web of Science ®Google Scholar
• Makadia HH, Siegel JS. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377–1397.
   Google Scholar
• Dang L, Liu J, Li F, et al. Targeted delivery systems for molecular therapy in skeletal disorders. Int J Mol Sci. 2016;17:428 . Epub 2016/03/25.10.3390/ijms17030428
   PubMed Web of Science ®Google Scholar
• Thamake SI, Raut SL, Gryczynski Z, et al. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials. 2012;33:7164–7173 . Epub 2012/07/17.10.1016/j.biomaterials.2012.06.026
   PubMed Web of Science ®Google Scholar
• Neale JR, Richter NB, Merten KE, et al. Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent. Bioorg Med Chem Lett. 2009;19:680–683 . Epub 2009/01/02.10.1016/j.bmcl.2008.12.051
   PubMed Web of Science ®Google Scholar
• Wang F, Chen L, Zhang R, et al. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. J Controlled Release. 2014;196:222–233 . Epub 2014/12/03.10.1016/j.jconrel.2014.10.012
   PubMed Web of Science ®Google Scholar
• Barbosa JS, Costa RR, Testera AM, et al. Multi-layered films containing a biomimetic stimuli-responsive recombinant protein. Nanoscale Res Lett. 2009;4:1247.10.1007/s11671-009-9388-5
   PubMed Web of Science ®Google Scholar
• Tejeda-Montes E, Smith KH, Rebollo E, et al. Bioactive membranes for bone regeneration applications: effect of physical and biomolecular signals on mesenchymal stem cell behavior. Acta Biomater. 2014;10:134–141.10.1016/j.actbio.2013.09.001
   PubMed Web of Science ®Google Scholar
• Yilgor P, Hasirci N, Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A. 2010;93:528–536.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cabello JC, Prieto S, Reguera J, et al. Biofunctional design of elastin-like polymers for advanced applications in nanobiotechnology. J Biomater Sci Polym Ed. 2007;18:269–286.10.1163/156856207779996904
   PubMed Web of Science ®Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–875.10.1002/jps.2600501018
   PubMed Web of Science ®Google Scholar
• Sze A, Erickson D, Ren L, et al. Zeta-potential measurement using the Smoluchowski equation and the slope of the current–time relationship in electroosmotic flow. J Colloid Interface Sci. 2003;261:402–410.10.1016/S0021-9797(03)00142-5
   PubMed Web of Science ®Google Scholar
• Wagner M, Rinkenauer AC, Schallon A, et al. Opposites attract: influence of the molar mass of branched poly(ethylene imine) on biophysical characteristics of siRNA-based polyplexese. RSC Adv. 2013;3:12774–12785.10.1039/c3ra42069 h
   Web of Science ®Google Scholar
• Byler DM, Susi H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers. 1986;25:469–487.10.1002/(ISSN)1097-0282
   PubMed Web of Science ®Google Scholar
• Popescu MC, Vasile C, Craciunescu O. Structural analysis of some soluble elastins by means of FT-IR and 2D IR correlation spectroscopy. Biopolymers. 2010;93:1072–1084.10.1002/bip.21524
   PubMed Web of Science ®Google Scholar
• Miller FA, Wilkins CH. Infrared spectra and characteristic frequencies of ınorganic ıons. Anal Chem. 1952;24:1253–1294.10.1021/ac60068a007
   Web of Science ®Google Scholar
• Ray S, Shard AG. Quantitative analysis of adsorbed proteins by X-ray photoelectron spectroscopy. Anal Chem. 2011;83:8659–8666 . Epub 2011/10/04.10.1021/ac202110x
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9:223–243.10.1016/j.nantod.2014.04.008
   PubMed Web of Science ®Google Scholar